Key Takeaways
- Dr. Jason Kirby, Medical Director at PursueCare, has been named a 2025 ASAM Distinguished Fellow, recognizing his leadership in addiction treatment.
- PursueCare will showcase its innovative virtual addiction treatment platform at the 56th ASAM Conference in April 2025.
- The company’s mission focuses on increasing access to addiction care through telehealth and personalized support services.
Celebrating Innovation in Addiction Medicine
PursueCare, a provider of virtual addiction treatment and pharmacy services, will participate in the 56th Annual American Society of Addiction Medicine (ASAM) Conference, taking place from April 24-27, 2025, in Denver, Colorado. This prestigious event attracts leading experts in addiction medicine to discuss advancements in science, practice, and policy in the field.
At this event, Dr. Jason Kirby, DO, MBA, DFASAM, PursueCare’s Medical Director, will be honored as a 2025 ASAM Distinguished Fellow. This accolade is among the highest honors bestowed by ASAM and highlights Dr. Kirby’s commitment to evidence-based treatment and his efforts to enhance access for individuals dealing with substance use disorder (SUD).
Dr. Kirby expressed his gratitude, stating, “I began this journey nearly a decade ago with a mission to provide compassionate, science-backed care for people living with addiction. Being recognized as a Distinguished Fellow by ASAM is a profound honor. It’s a privilege to stand alongside so many esteemed leaders who are transforming the future of addiction medicine.”
With board certifications in both addiction medicine and family medicine, Dr. Kirby’s expertise extends to healthcare policy and population health. His leadership reflects PursueCare’s innovative approach to addiction treatment.
During the ASAM Conference, attendees are encouraged to visit PursueCare at Booth #325. The company will highlight its advanced virtual-first addiction treatment platform, featuring tools that provide 24/7 recovery support. This includes cognitive behavioral therapy (CBT), contingency management, and real-time monitoring—integrated within PursueCare’s secure mobile applications. These innovations aim to enhance the quality and accessibility of virtual addiction care.
Nick Mercadante, Founder and CEO of PursueCare, remarked, “Dr. Kirby’s recognition as a Distinguished Fellow is a proud moment for everyone at PursueCare. His tireless work to expand access and improve outcomes in virtual addiction treatment reflects our mission to reimagine what recovery looks like for people everywhere.” PursueCare is committed to transforming addiction care through scalable and data-driven solutions that resonate with diverse patient needs.
PursueCare offers personalized virtual addiction treatment across several states, including Connecticut, Kentucky, Massachusetts, Maine, New Hampshire, Ohio, and West Virginia. Their mission emphasizes increasing access through telehealth, connecting patients with a multidisciplinary team that delivers medical care, counseling, psychiatry, and pharmacy services. They also provide FDA-authorized digital cognitive behavioral therapy options, RESET® and RESET-O®, to support continuous recovery.
For more information about PursueCare and its services, visit www.pursuecare.com and www.reachforreset.com.
The content above is a summary. For more details, see the source article.
